The trapeziometacarpal joint (TMCJ) is the most common hand joint affected by osteoarthritis (OA), and trapezium implant arthroplasty is a potential treatment for recalcitrant OA. This meta-analysis aimed to investigate the efficacy and safety of various trapezium implants as an interventional option for TMCJ OA. Web of Science, PubMed, Scopus, Google Scholar, and Cochrane library databases were searched for relevant studies up to May 2022. Preferred Reported Items for Systematic Review and Meta-Analysis guidelines were adhered to and registered on PROSPERO. The methodological quality was assessed by National Heart, Lung, and Blood Institute tools for observational studies and the Cochrane risk of bias tool. Subgroup analyses were performed on different replacement implants, the analysis was done via Open Meta-Analyst software and P values < 0.05 were considered statistically significant.

A total of 123 studies comprising 5752 patients were included. Total joint replacement (TJR) implants demonstrate greater significant improvements in visual analogue scale pain scores postoperatively. Interposition with partial trapezial resection implants was associated with the highest grip strength and highest reduction in the Disabilities of the Arm, Shoulder, and Hand score. Revision rates were highest in TJR (12.3%), and lowest in interposition with partial trapezial resection (6.2%).

Total joint replacement and interposition with partial trapezial resection implants improve pain, grip strength, and DASH scores more than other implant options. Future studies should focus on high-quality randomized clinical trials comparing different implants to accumulate higher quality evidence and more reliable conclusions.

Objective: Unicompartmental knee arthropasty (UKA) has recently attracted increased popularity and usage, though issues exist regarding tibial component failure. UKA instability may be due to insufficient bony support at the proximal tibia. Pre-operative knowledge of ‘safe’ resurfacing depths offering subchondral bony support could help minimize UKA instability. We recently developed a novel CT imaging tool (CTTOMASD) which assesses subchondral bone mineral density (BMD) in relation to depth from the subchondral surface. The objective of this work was to determine the in-vivo precision of CT-TOMASD safe resurfacing depths in human tibial compartments.

Seven knees from seven donors (2M:5F; age:46+/−11) were scanned three times via QCT (GE Lightspeed; BMD Phantom; 0.625x0.625x0.625mm resolution). CTTOMASD regional analyses were performed for medial and lateral compartments; outputting density versus depth plots fit with polynomial regression equations. As density decreases with increased depth from the subchondral surface, a density threshold of 300mg/ cm3 was arbitrarily set to correspond with the safe resurfacing depth. The 300mg/cm3 density threshold corresponds to the average density of subchondral trabecular bone, and is ~2x the density of weak epiphyseal trabecular bone located beneath stiffer subchondral trabecular bone. Precision was defined using coefficients of variation (CV%).

In-vivo precision errors associated with CT-TOMASD safe resurfacing depths were less than 2.7%. CV% was 2.7% for the medial compartment depth and 2.6% for the lateral compartment depth.

CT-TOMASD demonstrates repeatable measures of safe resurfacing depths invivo.

Safe resurfacing depths are measured in relation to defined density thresholds which can be adjusted according to UKA design and patient specifics (e.g., size, sex). CT induces a low radiation dosage due to the low presence of radiosensitive tissues at the knee (~1/10th of a long-leg standing radiograph). CT-TOMASD has potential to be used as a pre-operative imaging technique for improved UKA stability and longevity.